Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy.
Fyfe, G, Fisher, R I, Rosenberg, S A, Sznol, M, Parkinson, D R, Louie, A CVolume:
13
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.1995.13.3.688
Date:
March, 1995
File:
PDF, 702 KB
english, 1995